Physician Portal

An overview of 2RT

2RT™ Retinal Rejuvenation is Nova Eye Medical’s proprietary, patented laser therapy that stimulates a biological healing response in the eye to treat the intermediate stages of age-related macular degeneration (AMD) and Clinically Significant Macular Edema (CSME).


Browse the 2RT Bibliography to review peer-review papers, articles, posters and book chapters. The bibliography can be customized based on date, topic, publication, language and/or author.


Download a number of clinical and educational resources, including white papers and tech notes.

Product Information

Physician Stories

Hear from your colleagues first-hand about the positive impact 2RT™ has had on their patients – and their practice.

2.Guymer RH, Wu Z, Caruso E, et al. Sub-Threshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2018 Sep 20. pii: S0161-6420(18)32135-3.

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More


We are thrilled to announce that 2RT® Retinal Rejuvenation Therapy now forms part of Nova Eye Medical Limited.

From our base in Fremont, California, our team is working hard to develop 2RT® as a potential breakthrough therapy for patients with intermediate age-related macular degeneration (iAMD).

Continue to the website.

Nova Eye Medical Inc.
41316 Christy Street, Fremont,
California 94538

LinkedIn Facebook Youtube
Contact us Visit